Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.06 | N/A |
| PEG Ratio (TTM) | 18.22 | N/A |
| P/S Ratio (TTM) | 2.43 | N/A |
| P/B Ratio (TTM) | 1.29 | N/A |
| P/FCF Ratio (TTM) | 11.91 | N/A |
| Price to 5YR AVG Earnings Ratio | 16.09 | N/A |
| Price to 5YR AVG FCF Ratio | 15.04 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.22% | N/A |
| ROE (TTM) | 11.12% | N/A |
| Net Profit Margin (TTM) | 20.18% | N/A |
| ROIC 5YR AVG | 9.06% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.11% | 11.83% | 17.03% |
| Revenue | 4.51% | 13.11% | 9.76% |
| Net Income | 1.29% | 11.41% | 18.14% |
| Cash Flow | 107.62% | 67.66% | 29.95% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.25 | N/A |
| Quick Ratio (TTM) | 0.25 | N/A |
| D/E Ratio (TTM) | 0.19 | N/A |
| Interest Coverage (TTM) | 3.20 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.09 | N/A |
| LTL to 5YR AVG FCF | 1.28 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.05% | N/A |